B

BOLT

BOLT

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
50%Neutral
Buy/Sell Ratio9% buys
BearishBullish
BOLT Live QuoteReal-time
$4.91
+$0.72(+17.18%)1M
Day Range$4.87 – $5.21
Open$5.05
Previous Close$5.06
Volume60.4K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$13.19M
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-14.00
Price to Book1.6
Dividend Yield0.65%
Beta (Volatility)1.01
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $4.91 (39%)
Low: $3.10High: $7.78
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$41.00-72.7% upside

Insider Buys

8

$13K

Insider Sales

3

$128K

Total Volume

$141K

16 transactions

Net Activity

$116K

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
70CONFIDENCE

Sentiment Rating

Moderate Accumulation

CEO Conviction Index

High Conviction Accumulation

Key Drivers

  • •Heavy distribution: sales represent 91% of total transaction value.
  • •Minor cluster buying: 2 unique insiders purchased shares.
  • •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
  • •CFO buying activity detected. Statistical studies show CFO purchases have high predictive power due to their direct visibility into balance sheet details.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

S - Sale Insiders

0 buys5 sells

$81.29M total

Q
2

Quinn William P.

Pres, CEO, CFO

4 buys1 sells

$65K total

Y
3

Yonehiro Grant

COO

0 buys1 sells

$44K total

N
4

Nemec Sarah

SVP, Finance, PAO

4 buys1 sells

$32K total

Trading History
BOLT insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Sep 16, 2026

2 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell17.3K$-13176.00$0

Jun 5, 2026

5 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell17.1K$509.00$8.69M

Sep 16, 2026

2 months ago

Yonehiro Grant

COO

COO
Sell13.2K$3.32$44K

Jun 5, 2026

5 months ago

Nemec Sarah

SVP, Finance, PAO

SVP
Buy509$3.88$2K

Sep 16, 2026

2 months ago

Nemec Sarah

SVP, Finance, PAO

SVP
Sell7.8K$3.32$26K

Jun 5, 2026

5 months ago

Quinn William P.

Pres, CEO, CFO

CEO
Buy637$3.88$2K

Sep 16, 2026

2 months ago

Quinn William P.

Pres, CEO, CFO

CEO
Sell17.6K$3.32$58K

Dec 5, 2025

11 months ago

Quinn William P.

Pres, CEO, CFO

CEO
Buy125$4.61$576

Dec 5, 2025

11 months ago

Nemec Sarah

SVP, Finance, PAO

SVP
Buy125$4.61$576

Dec 5, 2025

11 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell2.3K$125.00$289K

Jun 6, 2025

17 months ago

Nemec Sarah

SVP, Finance, PAO

SVP
Buy125$5.49$687

Jun 6, 2025

17 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell23.9K$125.00$2.99M

Jun 6, 2025

17 months ago

Quinn William P.

Pres, CEO, CFO

CEO
Buy125$5.49$687

Dec 16, 2024

23 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell13.9K$5000.00$69.31M

Dec 16, 2024

23 months ago

Quinn William P.

Pres, CEO, CFO

CEO
Buy5.0K$0.57$3K

Dec 16, 2024

23 months ago

Nemec Sarah

SVP, Finance, PAO

SVP
Buy5.0K$0.57$3K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
BOLT Buy Conviction9%
Industry Rank#0 of 569
Volume Contribution0.0%
Total Industry Activity$16.52B

BOLT has an insider buy conviction of 9%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for BOLT

Over the last 90 days, corporate insiders at BOLT (BOLT) engaged in a total of 16 transactions reported via SEC Form 4 filings. Among these, 8 were open-market purchases and 3 were sales. The total volume of insider trading reached $141K.

The net insider activity for BOLT shows a net selling bias of $116K. This activity represents a 9% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 13.9K shares valued at $69.31M on Dec 16, 2024.

Live Market News & Developments
Aggregated real-time headlines for BOLT (BOLT)
6 updates

Bolt makes inflammation play with Prana reverse merger, $120M financing

Fierce Biotech28d ago

Lucid stock jumps on 25,000 robotaxi deal with Europe's Bolt

Yahoo Finance64d ago

BOLT - Bolt Biotherapeutics Inc Stock Price and Quote

Finviz176d ago

Bolt Biotherapeutics, Inc. (BOLT) Reports Q1 Loss, Lags Revenue Estimates

Yahoo Finance192d ago

Bolt Biotherapeutics: BOLT Stock Price Quote & News

Robinhood1216d ago

Shoot with confidence: Explore the best stock options for Browning X-Bolt rifles

gohunt1122d ago

FAQs About BOLT Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for BOLT.

Based on SEC Form 4 disclosures, the Insider Confidence Score for BOLT is currently 70/100, which reflects a moderate accumulation bias. This calculation accounts for a total of 8 purchases and 3 sales by company executives over the last 90 days.

The CEO Conviction Index for BOLT is rated as "High Conviction Accumulation". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.